神经纤维瘤病中前列腺特异性膜抗原摄取增高
一名51岁男性神经纤维瘤病患者因前列腺特异性抗原升高和背痛行镓-前列腺特异性膜抗原PET/CT检查,前列腺未见异常摄取,但左肺、胸部和右侧髂骨见摄取(肺活检证实为肺鳞状细胞癌),皮肤纤维瘤病灶亦见广泛摄取。本例表明良性神经纤维瘤病可出现PSMA摄取。
要点
- 神经纤维瘤病的良性皮肤纤维瘤病灶可显示PSMA摄取。
- PSMA PET/CT中前列腺外摄取需结合活检鉴别恶性病变。
- 本例左肺、胸部和右侧髂骨摄取经肺活检证实为肺鳞状细胞癌。
核心结论
- 本例表明良性神经纤维瘤病可出现PSMA摄取。
研究设计与样本
- 个案报道:一名51岁男性,有30年神经纤维瘤病史,因前列腺特异性抗原升高2个月和背痛行镓-PSMA PET/CT检查以排查前列腺癌。
主要发现
- PSMA PET/CT示前列腺无异常摄取。
- 左肺、胸部和右侧髂骨见PSMA摄取,经肺活检证实为肺鳞状细胞癌。
- 皮肤纤维瘤病灶亦见广泛PSMA摄取。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 51-year-old man with 30-year neurofibromatosis and 2-month elevated prostate-specific antigen and back pain underwent a Ga-prostate-specific membrane antigen (PSMA) PET/CT scan for possible prostate cancer. Prostate-specific membrane antigen PET/CT imaging showed no abnormal uptake of the prostate. However, in addition to PSMA uptake in his left lung, thorax, and right ilium, which was confirmed being a lung squamous cell carcinoma by a lung biopsy, widespread uptake was also observed in his skin fibroma lesions. This case demonstrates that benign neurofibromatosis could have uptake of PSMA.
引用
- Wang Y, Zeng C, Liu H, et al. Increased Prostate-Specific Membrane Antigen Uptake in Neurofibromatosis. Clin Nucl Med. 2020. PMID: 32332318. doi:10.1097/RLU.0000000000003039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。